Latest news
Novo Nordisk's Pill Launch Faces a Jury of Divided Analysts - AD HOC NEWSAD HOC NEWS · Mon, 10 Aug 2026 11:11:36 GMTIs Novo Nordisk Positioned for Recovery in 2026 Amid Rising Competition and AI Innovations? - TradingKeyTradingKey · Sun, 09 Aug 2026 14:57:12 GMTNovo CEO looks to speed up R&D as share drop shows gap with Lilly - reuters.comreuters.com · Wed, 05 Aug 2026 15:33:40 GMTNovo CEO says setbacks demand faster research, purchases - RTE.ieRTE.ie · Wed, 05 Aug 2026 07:28:56 GMTNovo CEO faces investor grilling after outlook hike soured by pipeline concerns - SRN NewsSRN News · Wed, 05 Aug 2026 06:26:22 GMTNovo Nordisk Faces Competitive Pressures Amid Drug Setbacks - Intellectia AIIntellectia AI · Sun, 02 Aug 2026 08:31:09 GMTNovo Nordisk must face shareholder lawsuit over CagriSema trial claims - eciks.orgeciks.org · Fri, 31 Jul 2026 07:00:00 GMTUS judge says Novo Nordisk must face lawsuit over CagriSema - pharmaphorumpharmaphorum · Wed, 29 Jul 2026 07:00:00 GMT